Anatomy and Neuroscience - Theses

Permanent URI for this collection

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    The effects of stress on the onset and progression of Huntington's disease in a transgenic mouse model
    MO, CHRISTINA ( 2014)
    Huntington’s disease (HD) is a neurodegenerative disorder largely governed by genetics. The cause of the disease is a fully penetrant gene mutation, inherited by autosomal dominant transmission. The length of this mutation also predicts the age of disease onset, which can range from childhood to late adulthood. Work from our lab on the R6/1 transgenic mouse model of HD was the first to show that environmental factors can alter symptom progression. Environmental enrichment and voluntary wheel running delayed or ameliorated the triad of motor, affective and cognitive dysfunctions in HD mice. Recent clinical studies also suggest that lifestyle factors can affect the age of onset. Currently, there are no treatments to slow or change the course of HD so environmental interventions may offer a feasible approach to extend the symptom-free years in HD gene-positive individuals. There is evidence to suggest that the stress response is abnormal in HD mice and patients. The present study is the first to investigate the impact of stressors on the onset and progression in an animal model of HD. We used an acute (Chapter 3) and two chronic stress paradigms (Chapters 4 and 6) to assess the impact on characteristic symptoms of HD. We also extended the phenotyping of R6/1 HD mice to include behaviours of ethological relevance (Chapter 5). All 3 stress protocols were able modify various functions in R6/1 HD mice, notably accelerating cognitive decline and further impairing olfactory deficits. This work contributes data for sex differences in the HD phenotype and to the general stress literature. Importantly, we show that stress is not only able to modulate specific behaviours in HD mice, but that the gene mutation may confer a susceptibility to the negative effects of stress. Therefore, behavioural management therapy in combination with other lifestyle changes may help manage the course of the disease in gene positive individuals.
  • Item
    Thumbnail Image
    Depression in Huntington's disease: Modulation of environment and gender
    DU, XIN ( 2012)
    Of the plethora of symptoms that arise in HD, depression is the most diagnosed psychiatric symptom, with 30-50% of patients developing depression. This makes depression far more prevalent in the HD population than in the general populace and indeed, significantly more conspicuous compared to other neurodegenerative diseases such as Parkinson’s or Alzheimer’s disease. Due to depression’s ubiquity, impact and also the fact that it can appear decades before crippling motor symptoms, treatment and management of depression would significantly prolong the symptom-free period of patients’ lives. The overrepresentation of depression is most likely an endemic reflection of pathophysiology caused by the HD mutation. However, the aetiology of depression in the context of HD has not been well understood. The hypothalamic-pituitary-adrenal (HPA) axis is the major endocrine system responsible for stress adaptation and its dysfunction has been implicated in clinical depression. Few studies have examined the HPA-axis in HD to date. Our group has previously found, using the R6/1 mouse model of HD, a female-specific depression-like behavioural phenotype. In this thesis, examining the HPA-axis in these animals, it was found that female, but not male, R6/1 mice displayed a hyperactive HPA-axis in response to stressors. Further pharmacological challenges, gene expression analyses and in vitro studies discerned the source of the abnormality to a hypersensitive adrenal gland; a novel finding of a peripheral source for what has been largely seen as a centrally mediated pathology. Environmental factors have been found to produce significant modulation to the progression of HD. Previously, our lab has shown that environmental enrichment is able to delay the onset of various symptoms in the R6/1 mice, including depression-like behavioural phenotype in the female mice. In this thesis, environmental enrichment was also found to be able to rescue the abnormalities of the HPA-axis both in vivo and in vitro. One possible mechanism of such rescue by environmental enrichment is mediated through increased glucocorticoid receptor gene expression in the adrenal gland. Furthermore, experiments were carried out to dissect the influences of sex hormones toward explaining the sexually-dimorphic manifestation of this phenotype. Abnormality of the hypothalamic-pituitary-gonadal axis was found in both male and female R6/1 mice. Ovariectomy altered HPA-axis response in female mice, correlating with female R6/1 specific increases in estrogen receptor α gene expression in the adrenal gland. The findings in this thesis are the first to establish a peripheral origin of the HPA-axis dysfunction. It is also a first in showing that environmental enrichment can exert peripheral specific benefits. Sex-specificity of this phenotype is also a novel observation and may be due to female-specific adrenal alterations of estrogen receptor α gene expression. Clinical implications of these findings include prospective new biomarkers as well as opening up the way for potentially new targets for future treatments. Furthermore, these findings raise the consciousness regarding the importance of peripheral changes in HD and the importance of sex dimorphism in the disease progression of HD, two areas that have not been well studied.
  • Item
    Thumbnail Image
    A study of depression in Huntington's disease
    Pang, Terence Yeow-Chwen ( 2008)
    Huntington’s disease (HD) is an inherited neurodegenerative disorder that is caused by a mutation of a single gene, huntingtin. The disease is more commonly known for the characteristic choreiform movements that develop in the later, more advanced stages of the disease. However, cognitive deficits and psychiatric symptoms are frequently observed prior to the onset of the motor symptoms. Little is known about the pathological bases for the neuropsychiatric features which include increased irritability and heightened aggression. Depression affects 30-50% of HD patients and is the most commonly diagnosed psychiatric symptom. This is proportionally higher than in the general population and it is possible that inherent pathological changes in the HD brain render a HD-gene positive individual more susceptible to depression. Using a variety of behavioural tests, the R6/1 transgenic mouse model of HD was found to display altered responses reflective of depression-related behaviour, indicating that the HD mutation confers a genetic susceptibility for developing depression. The behavioural alterations were more robust in female HD mice reflecting a possible sex-dependent manifestation of the depression symptoms in the human HD population that has yet to be investigated. The onset and rate of progression of HD is strongly influenced by the environment and the development of depression is similarly impacted upon by environmental factors (e.g. stress, negative life events). The experimental paradigms of environmental enrichment and wheel-running slow the development of motor and cognitive symptoms in R6/1 HD mice and the present study reports that both paradigms also correct the depression-related behavioural phenotype. This study also found that HD mice had muted responses to two common classes of antidepressant drugs, highlighting the need for a detailed examination of the efficacy of drug treatments in HD patients. Depression susceptibility is linked to genetic variance in the human population and studies of gene candidates in mutant mice report the detection of behavioural phenotypes similar to the present study. The depression-related behavioural phenotype of the R6/1 HD model was found to be associated with early down-regulations in mRNA levels of the ii serotonin (5-HT) 1A and 5-HT 1B receptors in the cortex and the hippocampus. Additionally, female HD mice had reduced cortical 5-HT transporter gene expression. Collectively, these findings indicate that a disruption of serotonergic signaling in the HD brain contributes to the development of depression in HD. Brain-derived neurotrophic factor (BDNF) gene expression is down-regulated in the HD brain, however the expression pattern of exon-specific splice variants was previously unknown. This study reports that BDNF mRNA levels are reduced in the hippocampus by an early age but also reports that individual exon-specific transcripts are differentially down-regulated in males and females, although the functional relevance of this remains to be investigated. Overall, this study has demonstrated that the R6/1 transgenic mouse model of HD is ideal for further investigating the occurrence of depression in pre-motor symptomatic HD. It has also identified alterations in gene expression of key components of neuronal signaling which might be linked to the molecular basis of depression.